TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage drug development company developing life-improving medicines to treat degenerative muscle diseases, today announced four poster presentations at the 31st Annual Congress of the World Muscle Society (WMS). The Congress will take place in Hiroshima, Japan, from Sept. 29 to Oct. 3, 2026.

Details of the scientific posters at WMS:

Date & Time: Wednesday, Sept. 30, 5:15-6:15 p.m. JST

Poster 2.74P: BASECAMP: A Phase 2a Dose Comparison and Exploratory Efficacy Study of Forazapadin (SAT-3247) in Ambulatory Boys with Duchenne Muscular Dystrophy
Presenter: Anne M. Connolly, MD, Chief of the Division of Neurology at Nationwide Children’s Hospital

Poster 2.75P: TRAILHEAD: An Open-Label Study Evaluating Long-Term Safety and Efficacy of Forazapadin (SAT-3247) in Adults with Duchenne Muscular Dystrophy (DMD)
Presenter: Anne M. Connolly, MD, Chief of the Division of Neurology at Nationwide Children’s Hospital

Poster 2.68eP: Preclinical to human translation of regenerative index: quantification of progressive muscle degeneration and disease-modifying treatment response
Presenter: Ryan Mitchell, PhD, Satellos Senior Vice President, Head of Corporate Development

Date & Time: Wednesday, Sept. 30, 5:15-6:15 p.m. JST

Poster 3.31eP: Rationale and design of a safety, tolerability, and long-term efficacy study of Forazapadin (SAT-3247) in facioscapulohumeral muscular dystrophy (FSHD)
Presenter: Wildon Farwell, MD, Satellos Chief Medical Officer

The Satellos posters will be available in the Presentations and Publications section of the Satellos website.

ABOUT FORAZAPADIN
Forazapadin is a proprietary, oral, small molecule drug candidate being developed by Satellos as a novel approach to regenerating skeletal muscle lost in Duchenne muscular dystrophy (DMD) and other degenerative muscle diseases or injury conditions. Forazapadin targets AAK1, a key protein identified by Satellos as capable of helping restore the body’s natural muscle repair and regeneration biology, a fundamental process that is disrupted in DMD and other degenerative conditions. By inhibiting AAK1 forazapadin treatment aims to re-establish a biochemical signal needed to support muscle regeneration. Satellos is advancing forazapadin as a potential treatment for DMD that is independent of dystrophin and applicable regardless of exon mutation status as either a stand-alone or adjunctive therapy, with ongoing Phase 2 clinical studies including BASECAMP, a global, randomized, placebo-controlled study in pediatric participants, and TRAILHEAD, an open-label study in adult participants.

The Company previously referred to the program as SAT-3247 and expects to transition to broader use of the INN in future scientific, regulatory and corporate communications

ABOUT SATELLOS BIOSCIENCE INC.
Satellos is a clinical-stage drug development company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, Satellos has developed forazapadin, an orally administered small molecule AAK1 inhibitor designed to address deficits in muscle repair and regeneration. Forazapadin is being evaluated as a potential disease-modifying treatment, initially for Duchenne muscular dystrophy (DMD), in two Phase 2 clinical trials: BASECAMP in pediatric participants with DMD and TRAILHEAD in adults living with DMD. Satellos plans to submit an Investigational New Drug application and begin clinical research to investigate the use of forazapadin in individuals living with facioscapulohumeral muscular dystrophy (FSHD) in the second half of 2026 and has identified additional muscle diseases and injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and plans to pursue these opportunities in future clinical development. For more information, visit www.satellos.com and connect with Satellos on X, LinkedIn, Facebook and Instagram.

NOTICE ON FORWARD-LOOKING STATEMENTS
This press release includes forward-looking information or forward-looking statements within the meaning of applicable securities laws regarding Satellos and its business, which may include, but are not limited to, statements regarding the possibility of pursuing regulatory approval for SAT-3247, the potential for SAT-3247 to represent a disease modifying approach to the therapeutic treatment of people living with DMD; anticipated benefits to patients from a small molecule treatment for DMD; the enrollment in, advancement and timing of results of SAT-3247 through clinical trials, including the BASECAMP and TRAILHEAD clinical trials; the pharmacodynamic properties and mechanism-of-action of SAT-3247; the potential of our approach in other degenerative muscle diseases and Satellos’ plans to pursue additional muscle diseases and injury conditions in future clinical development; SAT-3247’s prospective impact on DMD patients, patients with other degenerative muscle disease or muscle injury or trauma, and on muscle regeneration generally, including whether results observed in the TRAILHEAD study will continue to mature or will translate to the pediatric population studied in BASECAMP; the anticipated timing for an Investigational New Drug submission to the U.S. Food and Drug Administration for SAT-3247 for evaluation in facioscapulohumeral muscular dystrophy and the anticipated timing for the launch of a related Phase 2 clinical trial; Satellos’ technologies and drug development plans; and the company’s expectations regarding the sufficiency of its cash, cash equivalents and short-term investments to fund operations, including its expectation that its current cash resources will provide a runway through 2027. All statements that are, or information which is, not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, occurrences or developments, are “forward-looking information or statements.” Often, but not always, forward-looking information or statements can be identified by the use of words such as “shall”, “intends”, “believe”, “plan”, “expect”, “intend”, “estimate”, “anticipate”, “potential”, “prospective”, “assert” or any variations (including negative or plural variations) of such words and phrases, or state that certain actions, events or results “may”, “might”, “can”, “could”, “would” or “will” be taken, occur, lead to, result in, or, be achieved. Such statements are based on the current expectations and views of future events of the management of the Company. These statements are based on assumptions and subject to risks and uncertainties. In making forward looking statements, the Company has relied on various assumptions, including but not limited to: its ability to obtain future funding on favorable terms, if at all; obtaining positive results in its clinical trials, its ability to obtain necessary regulatory approvals; its ability to arrange for the manufacturing of its product candidates and technologies; and general business, market and economic conditions. Although management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release, may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including, without limitation, risks relating to the pharmaceutical and bioscience industry (including the risks associated with preclinical and clinical trials and regulatory approvals), the research and development of therapeutics, the results of preclinical and clinical trials, general market conditions and equity markets, economic factors and management’s ability to manage and to operate the business of the Company generally, including inflation and the costs of operating a biopharma business, and those risks and uncertainties described in more detail in the “Risk Factors” section of Satellos’ Annual Information Form dated March 27, 2026, and amended and restated short form base shelf prospectus dated August 11, 2026 (each of which is located on Satellos’ SEDAR+ profile) and incorporated by reference in Satellos’ Form F-10 filed with the Securities and Exchange Commission on August 11, 2026, and in Satellos’ public filings on EDGAR (sec.gov) and SEDAR+ (sedarplus.ca). Although Satellos has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Satellos does not undertake any obligation to publicly update or revise any forward-looking statement, whether resulting from new information, future events, or otherwise.

CONTACTS
Investors: Caitlin Lowie, Vice President, Investor Relations & Communications, ir@satellos.com
Media: Emily Williams, Senior Director, Communications, media@satellos.com

Highlights:

  • Two drill rigs mobilized for the inaugural drilling campaign at the newly discovered Nguni Prospect, a high-grade gold-in-soil anomaly with a strike length in excess of 6km.
  • One diamond drill rig will focus on the highest-grade portions of the soil anomaly with an initial drill plan comprising 18 holes for 3,500m.
  • A second reverse circulation drill rig will focus on testing the strike extension of the soil anomaly with 13 holes planned for 1,500m.
  • A step-out diamond drill program comprising 5 holes for 1,000m has been finalised to test the eastern extension of the Manga Gold Prospect, a promising gold-in-soil and gold-in-bedrock anomaly located 17km west of Nguni.

VANCOUVER, British Columbia, Sept. 15, 2026 (GLOBE NEWSWIRE) — Ongwe Minerals Inc. (TSXV: OGW) (NSX:ONG) (“Ongwe” or “the Company”) is pleased to announce the commencement of drilling at its newly discovered Nguni gold prospect, situated 17 km east of the Manga Gold discovery, at the Omatjete Gold Project.

Nguni is a large, high-grade, gold-in-soil anomaly discovered by Ongwe in May 2026 during a regional soil sampling program. The sampling program targeted the regionally significant Okondeka Fault Zone (OFZ), which hosts both WIA Gold’s Kokoseb Gold Deposit and Ongwe’s Manga Gold Discovery – see Figure 1. Situated 55 km east of Kokoseb and 17 km east of Manga, Nguni is being rapidly advanced through detailed surface work and drilling, with the aim of converting the target into a large-scale economic discovery.

Dave Underwood, Ongwe’s CEO commented: “The central portion of the Nguni gold anomaly has now been closely defined by infill soil sampling, with 50 soil samples above 300ppb Au, peaking at 1,310ppb Au. This represents a 6km long, high-grade soil anomaly similar in scale and tenor to the anomaly at the neighbouring Kokoseb gold deposit, before it was drilled. We are now embarking on the maiden, fully funded drill program at this exciting target. A diamond drill rig has been mobilized to test the highest-grade portion of the anomaly so that we can collect detailed geological, structural and mineralogical information upfront, in order to better guide the follow-on drill program. The lower grade (central) portions of the anomaly will be scout drilled using an RC rig, which provides a quick and relatively cheap method of establishing grade potential and allows for ranking of targets.

We are also planning a diamond step-out drill program at Manga over the highest grade and width portion of the bedrock anomaly defined earlier in the year. The priority bedrock anomaly starts east of the previous RC drilling at Manga, stretches for at least a 1000m and is still open to the east”.

Map illustrating the Nguni Gold Anomaly in relation to the Manga Gold Discovery and the initial soil sampling results at the Kokoseb Gold Deposit

Figure 1: Regional map illustrating the Nguni Gold Anomaly in relation to the Manga Gold Discovery and the initial soil sampling results at the Kokoseb Gold Deposit (54.2Mt at 1.04 g/t Indicated, 35Mt at 0.99 g/t Inferred, released 16 July 2026, ASX, WIA Gold). The image highlights the primary structural control of the Okondeka Fault Zone and the scale of initial gold-in-soil results across the three discoveries.

Nguni Prospect

The Nguni gold anomaly was discovered by Ongwe during regional soil sampling along the Okondeka Fault System in May 2026. The initial regional sampling was carried out on a 200 x 200m square grid and later infilled to 50 x 50m spacing over the anomalous areas. The Nguni area is flat lying and there is very little outcrop visible. The gold anomaly lies along narrow zones of metasediments between late to post orogenic granites and appears to be in-situ within residual soils.

The Nguni anomaly extends over 6 km of strike and includes targets with varying orientations, width and intensity. A two-pronged drill program has been planned as follows:

  • A diamond drill program of approximately 18 holes for 3,500m initially, starting in the northwest corner of the anomaly and covering the higher-grade soils in the northwestern and southeastern portions.
  • A scout drill program of approximately 1,500m using an RC rig. This program is aimed at first pass testing of the lower priority targets to establish economic potential and priority.
  • Either or both programs will be expanded or modified as indicated by the logging and assay results.

Geological mapping of the limited outcrop indicates that the targeted metasedimentary units predominantly dip toward the south-southeast and the initial holes will therefore be drilled toward the north, except for one RC line positioned on the nose of the fold closure. Detailed logging of the initial core will be used to refine the drill parameters. See Figure 2.

Heat Map showing Nguni soil sample results with the planned DD and RC drill collars plotted.

Figure 2: Heat Map showing Nguni soil sample results with the planned DD and RC drill collars plotted.

RC drilling underway at the Nguni gold anomaly.

Figure 3: RC drilling underway at the Nguni gold anomaly.

Manga Prospect

The Manga prospect was discovered during the initial regional Omatjete soil sampling program carried out in Q4 2024. The 200 x 200m regional soil grid outlined an arsenic and gold anomaly approximately 4.5km long and 1km wide at the widest point. Infill sampling to 100 x 25m tightened up the surface anomaly and provided follow-up targets. The soil sampling was followed up with two trenches and eleven RC scout holes. Ten of the eleven RC holes returned anomalous gold values, several with wide low-grade intercepts including 138m @ 0.22g/t Au in hole MRC006. As the Manga area is covered by calcrete and alluvial sediment cover, a decision was taken in early 2026 to drill vertical holes through the calcrete cover and sample the top of bedrock beneath. This exploration technique was pioneered by Osino Resources at Twin Hills and has proved effective in defining mineralised footprints in hard rock below calcrete cover. The results from this program indicate that the Manga prospect becomes wider and higher grade towards the east and it is now clear that the calcrete cover gets thicker towards the east, masking the gold mineralization in the bedrock beneath.

Manga Drilling

A diamond drilling program of 5 holes for 1,000 m is planned for the Manga east extension, with an average planned depth of 200 m. The initial holes will be oriented and drilled toward the northwest, but drill parameters may be modified by the detailed logging.

The Company also plans to undertake a calcrete sampling program to trace gold mineralization beneath the calcrete cover east of the current bedrock sampling extent. If the calcrete results confirm that the mineralized trend continues, the Company will use follow-up bedrock sampling to refine the target before testing it with diamond drilling.

Heat map showing the bedrock assay results improving east of the 2024 RC drill collars.

Figure 4: Heat map showing the bedrock assay results improving east of the 2024 RC drill collars. Black triangles indicate the planned DD drill collars to be drilled in Q4 2026.

Assay Method

During the soil sampling programs, the Company initially utilized the detectORE™ analytical technique, designed to enable the measurement of trace gold concentrations in geological samples using a portable X-Ray Fluorescence (pXRF) instrument. This process overcomes the traditional limitations of gold analysis by pXRF including low gold concentrations and metal peak interference. The method involves leaching 250g of sieved material in a sealed pouch with 500ml of GLIX-20™ lixiviant and a Collector Device (CD). Following a 16-hour tumble in a Maxi Mixer barrel to dissolve the gold, the CD is removed, rinsed, and analyzed for 150 seconds using detectORE™ mode firmware. This partial analysis technique is managed through pLIMS™ software with strict QA/QC protocols to identify relative gold anomalism. An extensive orientation program was carried out before putting the detectORE™ methodology into production by comparing soil, calcrete and rock chip sample assays with Aqua Regia and FireICP. The detectORE™ system performed extremely well and identified the same anomalies as the laboratory techniques in all conditions. The detectORE™ gold technique is designed for rapid on-site assessment and is not used for the formal quantification of gold content or the estimation of Mineral Resources.

As part of the current exploration program, all soil samples undergo initial multi-element analysis utilizing the Company’s in-house pXRF. All trace element anomalies, including base metal and arsenic anomalies are then analyzed through the Company’s detectORE™ system. Any area returning a value equal to or greater than 10 detectable Units (dU) are prioritized for follow-up soil sampling. All follow-up soil samples are analyzed via Fire Assay at the MSALAB facility in Omaruru, Namibia. The fire assay procedure starts by drying the <212u and +-250g soil sample. The sample is then pulverized to 85% passing 75 microns, from which a final 50g aliquot is taken for fire assay with an Atomic Absorption (AA) finish.

QA/QC

All of Ongwe’s sample assay results have been independently monitored through a quality assurance and quality control (“QA/QC”) program including the insertion of blind standards, blanks, and field duplicate samples. The Company maintains rigorous monitoring for both in-house and laboratory analyses to ensure data reliability. For the detectORE™ process, which provides rapid on-site assessment of gold anomalism, a Certified Reference Material (CRM) sample is inserted every 15 samples to monitor the performance of the pXRF instrument and the leaching efficiency. For the formal fire assay verification conducted at MSALABS, a CRM is inserted every 30 samples. This laboratory procedure involves precise pulverization and a 50g fire assay with an Atomic Absorption (AA) finish to provide formal quantification for prioritized bedrock samples.

Data Verification

Carl Joone, BSc. (Hons), the President and Co-Founder of Ongwe Minerals Inc., and a Qualified Person for the purposes of National Instrument 43-101, has verified all the data disclosed, including a review of the sampling procedures, chain of custody, and assay results underlying the disclosure, by plotting and verifying against raw data received. Mr. Joone noted no errors or omissions during the data verification process.

Qualified Person

Carl Joone, BSc. (Hons) is the President and Co-Founder of Ongwe Minerals Inc. and is a registered Professional Natural Scientist with the South African Council for Natural Scientific Professions (Pr. Sci. Nat. No. 172695) and a Qualified Person for the purposes of National Instrument 43-101. Mr. Joone has reviewed and approved the scientific and technical information in this news release.

About Ongwe Minerals Inc.

Ongwe Minerals Inc. is a Canadian listed gold exploration company focused on the discovery and advancement of new gold systems in Namibia. The Ongwe team, previously with Osino Resources (sold to Shanjin International), has a history of making and advancing gold discoveries in Namibia, including Osino’s Twin Hills (currently in construction) and Eureka deposits, and the advancement and sale of Auryx Gold’s Otjikoto gold deposit (in production, sold to B2Gold).

The Company’s current focus is on three promising gold projects in the emerging Northwest Damara gold belt in Namibia, with a focus on the Omatjete and Khorixas Gold Projects.

The Omatjete Gold Project is strategically located along the regional Okondeka Fault Zone, which also hosts the Kokoseb gold deposit (WIA Gold). Early surface work by Ongwe led to the discovery of the Manga Gold Prospect which has a 4.5km x 1km footprint of gold in soil and early scout drilling indicating gold in bedrock. Recent regional sampling in 2026 has led to the discovery of the large scale, high tenor Nguni anomaly 17km east of Manga. Nguni currently has a strike length of 6km and is open to the west, north and east. The Omatjete Project still has significant growth potential and work is ongoing to define further anomalies along the Okondeka Fault system.

The Khorixas Gold Project is situated just 60km west of Osino’s Eureka gold project, adjacent to the northern margin of the Damara Orogenic Belt. Khorixas hosts two large-scale surface discoveries called Belmont and K17. The Belmont prospect has a surface gold footprint of approximately 12 × 6km and lies between the regional scale, basin margin, Khorixas Fault and the Belmont Thrust Zone. Calcrete and grab sampling to date have indicated eighteen target areas.

ON BEHALF OF THE BOARD OF DIRECTORS
“Dave Underwood”
Chief Executive Officer

CONTACT INFORMATION
Ongwe Minerals Inc.
Dave Underwood, Chief Executive Officer
Email: dave@ongweminerals.com
Ongwe Minerals Inc.
Carl Joone, President & Co-Founder
Email: carl@ongweminerals.com


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Cautionary Statements Regarding Forward Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the use of proceeds from the Company’s future plans or prospects of the Company, including prospects for discovery of mineral resources or the results of future exploration programs. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking statements are necessarily based upon a number of assumptions that, while considered reasonable by management, are inherently subject to business, market and economic risks, uncertainties and contingencies that may cause actual results, performance or achievements to be materially different from those expressed or implied by forward-looking statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Other factors which could materially affect such forward-looking information are described in the risk factors in the Company’s most recent annual management’s discussion and analysis which is available on the Company’s profile on SEDAR+ at www.sedarplus.ca. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Photos accompanying this announcement are available at 

https://www.globenewswire.com/NewsRoom/AttachmentNg/5d720019-9e19-4bd3-ae78-44f04ee73de8

https://www.globenewswire.com/NewsRoom/AttachmentNg/b790238b-3b4e-42d3-bfca-2c1cb71bf0e1

https://www.globenewswire.com/NewsRoom/AttachmentNg/0c1d1e05-8c32-41c0-9131-3ad41ee69e0e

https://www.globenewswire.com/NewsRoom/AttachmentNg/1a58afc3-1d07-40e2-9829-862e7223d1f1

Limited-Edition Release Continues Distillery’s Celebration of the Art of Blending Through Whiskey, Visual Art and Community

BRECKENRIDGE, Colo., Sept. 15, 2026 (GLOBE NEWSWIRE) — Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S. and part of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is turning whiskey into a canvas with the sixth edition of its acclaimed Collectors Art Series. This year’s limited-edition release pairs Breckenridge’s award-winning whiskey-making with the bold, colorful vision of Colorado muralist, professional snowboarder and creative Pat Milbery, whose original label design celebrates the mountain spirit, community and craftsmanship that define Breckenridge.

For this year’s collaboration, the creative partnership comes to life with a new mural by Milbery at Tony P’s Bar & Pizzeria, located at 3000 Zuni St, Denver, CO 80211. The mural brings his signature style and the spirit of the Collectors Art Series into the local community, further reflecting the Distillery’s commitment to supporting artists and creative spaces. Each collaboration transforms a limited-edition whiskey release into a collectible work of art while supporting the creative community through charitable giving.

For Milbery, the collaboration is deeply personal. After moving to Breckenridge to pursue professional snowboarding, the mountain town became the backdrop for many of life’s defining moments, from launching his snowboarding career to discovering his artistic voice. Today, his signature murals can be found across four continents, where bold geometric forms, vibrant color palettes and nature-inspired imagery encourage connection, optimism and open-hearted living.

Inspired by the landscapes, friendships and unforgettable moments that shaped his journey, Milbery’s artwork captures the joyful spirit of Breckenridge through colorful mountain vistas, evergreen forests, radiant sunsets and symbolic elements that honor both community and loved ones who continue to inspire his work. The design also reflects the craft behind whiskey, drawing a parallel between the thoughtful blending of barrels, flavors and character that goes into each expression and Milbery’s own process of bringing together color, movement, memories and emotion to create a singular work of art.

“Everything about Breckenridge inspired the artwork. The friendships. The sunsets. The powder days. The evergreen forests. The crisp mountain mornings. The incredible community,” said Milbery. “The artwork also honors important people in my life, including loved ones who are no longer physically with us but continue to inspire me every day. I wanted the design to represent joyful energy, gratitude, community and the colorful journey that Breckenridge has been in my life.”

Milbery’s artwork will appear on the Breckenridge Barbados Cask Finish Whiskey, bottled at 90 proof and 45% ABV. The limited-edition expression showcases Breckenridge Distillery’s dedication to the art and craft of whiskey, bringing together carefully selected whiskey and the influence of Barbados cask finishing to create a distinctive expression. Just as Milbery thoughtfully layers color, texture and movement to create his artwork, Breckenridge’s whiskey-making process brings together distinct elements, from spirit and barrel to time and finishing, to create a finished whiskey with its own character and story.

Since its inception, the Collectors Art Series has become one of Breckenridge Distillery’s signature annual releases, highlighting acclaimed artists while reinforcing the Distillery’s longstanding support of the arts. Previous collaborators include Miles Toland, Abby Wren and Alexandrea Pangburn, each bringing a unique perspective to the series while helping raise funds for organizations that champion artists and creative spaces.

Breckenridge Collectors Art Series releases have earned numerous accolades, including 2023 Best Blended LTD Release and 2020 Icons of Whisky’s Campaign Innovator of the Year at the World Whiskies Awards, along with Gold and Double Gold medals at the San Francisco World Spirits Competition.

Breckenridge Collectors Art Series 6 will be available beginning September 15, 2026, exclusively at Breckenridge Distillery and the Main Street Tasting Room in Breckenridge, Colorado, for $125.

For more information about Breckenridge Distillery, visit breckenridgedistillery.com. Follow Breckenridge on Instagram @breckdistillery and become a fan at facebook.com/BreckDistillery. Age 21+. Always enjoy responsibly.

To learn more about Pat Milbery and view his work, visit Heart Space Studios at heartspacestudios.art, patmilbery.com and Sognar Creative Division at sognarcreativedivision.com, and follow @patmilbery on Instagram.

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

About Breckenridge Distillery

Founded in Colorado in 2008, Breckenridge Distillery is the “World’s Highest Distillery,” and is best known for its award-winning blended bourbon whiskey, a high-rye mash American-style whiskey.

One of the most highly awarded distilleries in the U.S., the Breckenridge Distillery is proudly a 3x Icons of Whisky and 10x winner of Best American Blended winner at the World Whiskies Awards by Whisky Magazine and a 4x winner of Colorado Distillery of the Year by the New York International Spirits Competition. Most recently, Breckenridge Port Cask Finish was named World’s Best Finished Bourbon at the 2024 World Whiskies Awards, joining Breckenridge High Proof, named World’s Best Blended Whiskey and Breckenridge Gin, named World’s Best Compound Gin at the World Gin Awards by Gin Magazine. Breckenridge spirits have been awarded 6 Double Golds at the San Francisco World Spirits Competition.

The Breckenridge Distillery is more than award-winning spirits, offering an immersive guest experience. Named as one of the country’s Top Visitor Attractions by Whisky Magazine, guests can dine at their award-winning restaurant, enjoy show-stopping cocktails, learn about their highly awarded spirits with an in-depth tasting, and get an inside look at their active production facility. New to the distillery, guests have the opportunity to blend their own whiskey as they learn the inner workings of whiskey production.

Breckenridge Distillery is a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide community to live their very best life.

To learn more about Breckenridge Distillery, visit www.breckenridgedistillery.com. Keep up with Breckenridge Distillery on Instagram by following @breckdistillery and become a fan at facebook.com/BreckDistillery. 

For more information about Tilray Brands, visit www.tilray.com and follow @tilray on Instagram, Twitter, Facebook, and LinkedIn.

Forward-Looking Statements

Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, “forward-looking statements”) under Canadian and U.S. securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the “safe harbor” created by those sections and other applicable laws. Forward-looking statements can be identified by words such as “forecast,” “future,” “should,” “could,” “enable,” “potential,” “contemplate,” “believe,” “anticipate,” “estimate,” “plan,” “expect,” “intend,” “may,” “project,” “will,” “would” and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections, or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses, or current expectations. Many factors could cause actual results, performance, or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly update such forward-looking statements to reflect new information, subsequent events, or otherwise unless required by applicable securities laws.

For further information, please contact

Media: news@tilray.com
Investors: investors@tilray.com
Breckenridge Distillery: jessie.unruh@breckenridgedistillery.com

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/c5107390-6a4e-49c9-a6a6-5f845427c134

https://www.globenewswire.com/NewsRoom/AttachmentNg/209f298a-228f-4040-bd31-cf0762d63ba8

Agreement geared towards potential orders of up to 1 tonne of titanium powder per month

MONTREAL, Sept. 15, 2026 (GLOBE NEWSWIRE) — PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, today announces its first contract toward a new titanium powder supply agreement with a U.S.-based materials distributor (the “Client”). The powder for this order has been produced by PyroGenesis’ NexGen™ plasma atomization process and is to be shipped this week. The Client’s identity and contract details will remain confidential for competitive reasons.

As disclosed in the Outlook section of the Company’s Q2 2026 earnings release, dated August 6, 2026, the Company has been in discussion with several companies regarding titanium powder orders, including a US-based materials distributor for a monthly supply agreement of up to 500 kg. Today’s contract represents the first commercial order arising from those discussions. The Client has since indicated that its potential monthly requirements could reach 1,000 kg (1 tonne); however, no commitment for recurring orders at that volume has been made.

The order is for Ti64 “fine” cut powder, with a particle size range of 20-80µm (microns). This powder is typically used in laser powder bed fusion (LPBF), an additive manufacturing technology widely used to produce complex, high-density components for aerospace, healthcare, and automotive industries. The Client supplies U.S. customers in the aerospace, defense, energy, and broader advanced manufacturing sectors.

“The contract announced today directly supports the strategic goals outlined in our April 29, 2026, press release: positioning the Additive Manufacturing Division for its next level of growth, with operations anticipated to be several times larger than those currently in place,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “This relationship with a well-connected materials distributor serving both the aerospace and defense sectors will help us expand our customer base in these two key industries that we have identified as central to achieving those strategic goals.”

PyroGenesis’ Technology Development for Additive Manufacturing

PyroGenesis is the inventor of the plasma atomization process and in fact coined the term “plasma atomization” in its original patent. Plasma atomization is often considered the gold standard process for the production of metal powder for additive manufacturing, also referred to as metal 3D printing.

After years of R&D, PyroGenesis redesigned its plasma atomization technology and launched NexGen™ to re-enter the powder production market by targeting higher quality and yields, at lower operating costs. The Company has since taken a deliberate approach to commercialization, progressing from gram-scale customer samples to 100-kg orders, and its first tonne-scale order in May 2023.

PyroGenesis produces titanium powders in particle size distribution ranges across three “cuts”:

  • Fine Cut, in particle sizes between 15–63 µm for use in laser powder bed fusion (LPBF).
  • Coarse Cut, in particle sizes between 45–106 µm for use in electron beam melting (EBM) and 45–150 µm in directed energy deposition (DED).
  • Off-Cuts, in particle sizes not currently used by the existing range of commercial printers, but which offers a high-quality feedstock for use in the production of high-quality metal alloys.

PyroGenesis’ titanium metal powder as produced by its NexGen™ plasma atomization system.

Image: PyroGenesis’ titanium metal powder as produced by its NexGen™ plasma atomization system.

INDUSTRY AND MARKET CONTEXT

  • The global 3D printing market specific to titanium powder is expected to increase from $214 million in 2023 to $1.4 billion by 2032.1
  • Titanium is classified as a critical mineral by both Canada2 and the U.S.3
  • Titanium is used by multiple industries, including space, aerospace, defense, consumer electronics, medical, hydrogen, and electric vehicles, due to its high strength-to-weight ratio and corrosion resistance.

About PyroGenesis Inc.

PyroGenesis leverages 35 years of plasma technology leadership to deliver advanced engineering solutions to energy, propulsion, destruction, process heating, emissions, and materials development challenges across heavy industry and defense. Its customers include global leaders in aluminum, aerospace, steel, iron ore, utilities, environmental services, military, and government. From its Montreal headquarters and local manufacturing facilities, PyroGenesis’ engineers, scientists, and technicians drive innovation and commercialization of energy transition and ultra-high temperature technology. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified, with ISO certification maintained since 1997. PyroGenesis’ shares trade on the TSX (PYR), OTCQX (PYRGF), and Frankfurt (8PY1) stock exchanges.

Cautionary and Forward-Looking Statements

This press release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of applicable securities laws. In some cases, but not necessarily in all cases, forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “targets”, “expects” or “does not expect”, “is expected”, “an opportunity exists”, “is positioned”, “estimates”, “intends”, “assumes”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking statements. Forward-looking statements are not historical facts, nor guarantees or assurances of future performance but instead represent management’s current beliefs, expectations, estimates and projections regarding future events and operating performance. Forward-looking statements are necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by PyroGenesis as of the date of this release, are subject to inherent uncertainties, risks and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Important factors that could cause actual results to differ, possibly materially, from those indicated by the forward-looking statements include, but are not limited to, the risk factors identified under “Risk Factors” in PyroGenesis’ latest annual information form, and in other periodic filings that it has made and may make in the future with the securities commissions or similar regulatory authorities, all of which are available under PyroGenesis’ profile on SEDAR+ at www.sedarplus.ca. These factors are not intended to represent a complete list of the factors that could affect PyroGenesis. However, such risk factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. You should not place undue reliance on forward-looking statements, which speak only as of the date of this release. PyroGenesis undertakes no obligation to publicly update or revise any forward-looking statement, except as required by applicable securities laws. Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQX Best Market accepts responsibility for the adequacy or accuracy of this press release.

For further information contact ir@pyrogenesis.com or visit http://www.pyrogenesis.com

_____________________
1
https://3dprint.com/313549/titanium-3d-printing-powders-to-reach-1-4b-by-2032/

2 https://www.canada.ca/en/campaign/critical-minerals-in-canada/critical-minerals-an-opportunity-for-canada.html

3 https://public-inspection.federalregister.gov/2025-16311.pdf

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/5b8b5bea-6909-44b7-ac08-2664cd5c55ab

VANCOUVER, British Columbia, Sept. 15, 2026 (GLOBE NEWSWIRE) — Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB) announces that it has received an unsolicited offer from an arm’s length third party for a proposed transaction for the sale of substantially all of the assets of CLC. The proposed transaction involves a different potential buyer and is not related to the proposed transaction announced by CLC on August 21, 2026. CLC has entered into a non-binding letter of intent in respect of the second offer.

The Special Committee of the Board of Directors (the “Special Committee“) formed in August 2026 will review the merits of the proposed transaction. The Special Committee is also continuing to review the merits of the original transaction proposal announced on August 21, 2026.   The Board of Directors of CLC has not approved the entering into of any definitive agreement for either transaction at this time. See “Special Committee” below.

Original Transaction

On August 21, 2026, CLC announced in a press release (the “August 21 Press Release“) that it had entered into a non-binding letter of intent (the “Initial LOI“) with a private Alberta corporation (the “Original Purchaser“), to engage in due diligence and negotiations regarding the terms of a proposed transaction (the “Original Transaction“) whereby the Original Purchaser would acquire all of the issued and outstanding common shares (the “Shares“) of the Company. The final structure of the Proposed Transaction has not been determined and, if the parties agree to proceed, will be set out in a definitive agreement between CLC and the Original Purchaser.

The Initial LOI contemplates an aggregate transaction value of $15,000,000 for 100% of the equity of the Company on a fully-diluted, cash-free, debt-free basis. The Initial LOI is non-binding and there can be no assurance that a definitive agreement for the Original Transaction will be entered into or that the Original Transaction contemplated by the Initial LOI, or any other transaction, will be completed.

Alternative Transaction

Subsequent to the execution of the Initial LOI and the issuance of the August 21 Press Release, the Company received an unsolicited offer from Medical Saints Ltd. an arm’s length third party (the “Alternative Purchaser“) for the sale of substantially all of the assets of CLC (the “Alternative Transaction“). In connection with the fiduciary obligations of the Board and the Special Committee, and as permitted by the exclusivity provisions of the Initial LOI, the Company entered into a non-binding letter of intent with the Alternative Purchaser effective September 11, 2026 for an Alternative Transaction (the “Second LOI”). No definitive agreement has been entered into in respect of the Original Transaction or the Alternative Transaction. “We are extremely pleased to move forward with the acquisition of the Christina Lake Cannabis assets. The scale of the cultivation platform is significant, but what makes this transaction particularly strategic for Medical Saints is the extraction infrastructure, processing capabilities, and expertise that Christina Lake has built. These assets complement our existing operations and materially expand what we can produce, process, and bring to market. Lucas Leone – Chief Executive Officer, Medical Saints Ltd.”

Unlike the Original Transaction, which contemplates an acquisition of the Shares, the Alternative Transaction contemplates the acquisition by the Alternative Purchaser of all of the assets of the Company (other than cash, cash equivalents, tax receivables and certain other assets to be agreed as excluded), free and clear of any encumbrances. The assets to be acquired would include all owned land and buildings and assigned commercial leases used in the business, all machinery, office equipment, computers, furniture and inventory, and all customer lists, proprietary data, historical records, trademarks, patents, copyrights and software.

The Second LOI provides for an aggregate purchase price of $18,000,000, on a cash-free, debt-free basis, payable in cash at closing and inclusive of a $2,000,000 advance payment on the purchase price (the “Advance”). The Advance would be delivered to the Company’s counsel, for the benefit of the Company, concurrently with the execution of a definitive agreement and would be credited against the purchase price at closing. In certain circumstances in which the transaction does not close as a result of the Alternative Purchaser’s failure to fund or a material breach by the Alternative Purchaser, the Advance would be retained by the Company as liquidated damages; in other circumstances, including a failure to close not caused by the Alternative Purchaser or a breach by the Company, the Advance would be repaid to the Alternative Purchaser.

Under the Second LOI, the parties would negotiate and enter into a definitive agreement for the Alternative Transaction within 40 days of executing the Second LOI, and would use reasonable commercial efforts to work towards a closing following the satisfaction or waiver of the applicable closing conditions. The Second LOI provides for an exclusivity period of 40 days, which is expressly subject at all times to the fiduciary duties of the Board, including its ability to consider, negotiate or respond to unsolicited bona fide proposals, and which is expressly subordinate to the Company’s existing contractual obligations to third parties, including its obligations under the Initial LOI.

Completion of the Alternative Transaction would be subject to a number of conditions, including the release and discharge of any encumbrances, negotiation and execution of a mutually agreed definitive agreement, receipt of all required regulatory, stock exchange, corporate and shareholder approvals, confirmation that no material adverse change has occurred, and the entering into of mutually agreed employment, consulting and/or transition services arrangements. The Alternative Purchaser is expected to offer employment to all of the Company’s employees engaged in the business on substantially comparable terms, with any related severance, termination or similar liabilities to be for the account of the Alternative Purchaser.

Term

The Second LOI will terminate in the following circumstances: (a) by written agreement of the parties; (b) upon the execution of a definitive agreement between CLC and the Alternative Purchaser; or (c) at the end of the exclusivity period (or any extension thereof).

Special Committee

A Special Committee of the Board (the “Special Committee“) was formed in August 2026 as described in the August 21 Press Release. The Special Committee’s role is to consider, evaluate and, if applicable, negotiate the strategic alternatives available to the Company, including the Original Transaction and the Alternative Transaction, and to make recommendations to the Board in connection therewith, including prior to the execution of any definitive agreement or the submission of any such transaction to the shareholders of the Company for a vote.   The Board of Directors of CLC has not approved the entering into of any definitive agreement for either transaction at this time.

Second LOI Non-Binding

The Second LOI is non-binding and does not create any binding legal rights or obligations, other than certain customary provisions – namely those relating to Legal Effect, Exclusivity, Termination, Confidentiality, Public Disclosure and General Provisions – which are binding upon execution. The Second LOI is governed by the laws of the Province of Ontario. As negotiations are ongoing, the Company can provide no assurance that it will agree on the final terms of, or execute, a definitive agreement with the Alternative Purchaser, or that the Alternative Transaction will be completed. Any such transaction would be subject to, among other conditions, the negotiation and execution of a definitive agreement and the receipt of all required shareholder, regulatory, stock exchange and other approvals.

If a definitive agreement with the Alternative Purchaser is executed, the Company expects that it will be required to hold a special meeting (the “Special Meeting“) of the Company’s shareholders to approve the Alternative Transaction. The Alternative Transaction is subject to receipt of the foregoing approvals and other customary closing conditions. Terms and conditions of the Alternative Transaction are expected to be disclosed in greater detail in a management information circular for the Special Meeting (the “Circular“). Following execution of the definitive Agreement, a Circular will be mailed to the Company’s shareholders. There are no finder’s fees payable by the Company in connection with the Alternative Transaction.

In the event that the Company executes a definitive agreement with either the Original Purchaser or the Alternative Purchaser, copies of such definitive agreement and the information circular for the special meeting of the Company’s shareholders to approve such transaction will be filed with Canadian securities regulators. Documents filed by the Company with Canadian securities regulators are available on the SEDAR+ profile of the Company at www.sedarplus.ca. Shareholders are urged to read any relevant materials when they become available. However, Shareholders do not need to take any action with respect to the Original Transaction or the Alternative Transaction at this time.

Counsel

Prelia Canada LLP is acting as the Company’s legal advisor.

About Christina Lake Cannabis Corp.

Christina Lake Cannabis is a licensed producer of cannabis under the Cannabis Act with a standard cultivation license and corresponding processing amendment from Health Canada as well as a research and development license. Christina Lake Cannabis’ facilities consist of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction, and a 342-acre property which includes approximately 100 acres of licensed outdoor grow space, greenhouses, and a dry room. CLC focuses its production on creating high-quality outdoor flower, extracts and distillate for its B2B client base.

On behalf of Christina Lake Cannabis:

“Jay McMillan”
Jay McMillan, Chairman

For more information about CLC, please visit: www.christinalakecannabis.com

Investor Relations and Media Inquiries
investors@clcannabis.com
1.888.410.0304

About Medical Saints Ltd:
Medical Saints Ltd. is one of Canada’s largest privately held federally licensed cannabis producers, operating a vertically integrated platform across cultivation, processing, manufacturing, product development and commercialization.

Medical Saints currently produces 100 tonnes (100,000 kilograms) of cannabis annually in Canada.

For more information, visit www.medicalsaints.com.

Media & Investor Contact:
Lucas Leone
Chief Executive Officer
Medical Saints Ltd.
Email: info@medicalsaints.com

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

All statements, other than statements of historical fact, contained in this press release constitute “forward-looking information” and “forward-looking statements” within the meaning of certain securities laws and are based on expectations and projections as of the date of this press release. Forward-looking information and forward-looking statements may relate to the Company, the Original Purchaser, the Alternative Purchaser, and to anticipated events or results, notably the negotiation and potential completion of the Original Transaction and/or the Alternative Transaction on terms substantially similar to those currently contemplated.

Statements regarding future results, performance, achievements, prospects, or opportunities of the Company, the Original Purchaser, the Alternative Purchaser, or similar statements concerning anticipated future events, results, circumstances, performance or expectations, notably the execution of a definitive agreement and the completion of a transaction with the Original Purchaser or the Alternative Purchaser, are also forward-looking statements. Forward-looking statements contained in this press release include, without limitation, those related to: (i) the Board’s review and evaluation of the Second LOI; (ii) the relative benefits to the Company and its shareholders of the Original Transaction and the Alternative Transaction; (iii) the ability of the Company and either the Original Purchaser or the Alternative Purchaser to negotiate and execute a definitive agreement; (iv) the Company’s receipt of all necessary approvals (including shareholder approval, any required court approval, regulatory and stock exchange approvals, and any approvals required in connection with the transfer or reissuance of the Company’s licences); and (v) the final terms of any definitive agreement.

Forward-looking statements are based on expectations, estimates, and projections as of the time of this press release. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by the Company, the Original Purchaser or the Alternative Purchaser as of the time of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. These estimates and assumptions may prove to be incorrect.

Many of these uncertainties and contingencies can directly or indirectly affect, and could cause, actual results to differ materially from those expressed or implied in any forward-looking statements. There can be no assurance that the Company, the Special Committee, and the Board will be able to negotiate or approve a definitive Agreement on terms acceptable to each of them and to either the Original Purchaser or the Alternative Purchaser, as applicable. Future events could differ materially from what is currently anticipated by the Company, the Original Purchaser or the Alternative Purchaser.

By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and specific, and risks exist that estimates, forecasts, and other forward-looking statements will not be achieved or that assumptions do not reflect future experience. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. Readers are cautioned not to place undue reliance on these forward-looking statements as a number of important risk factors and future events could cause the actual outcomes to differ materially from the beliefs, plans, objectives, expectations, anticipations, estimates, assumptions, and intentions expressed in such forward-looking statements. All of the forward-looking statements made in this press release are qualified by these cautionary statements and those made in the Company’s other filings with the securities regulators of Canada including, but not limited to, the cautionary statements made in the relevant portion of the Company’s Management Discussion & Analysis prepared as of June 29, 2026, for the financial year ended February 28, 2026. The foregoing list of factors that may affect future results is not exhaustive and new, unforeseeable risks may arise from time to time. The Company disclaims any intention or obligation to update or revise any forward-looking statements or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law.

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the launch of VitalHub AI Scribe, an ambient clinical intelligence (“ACI”) solution that captures conversations, identifies clinically relevant information, and automatically generates documentation, including case notes, transcriptions, client summaries, and patient summaries. By transforming conversations into structured documentation, AI Scribe helps health and human services professionals spend more time with patients and clients and less time completing paperwork. AI Scribe is going to be offered in VitalHub’s CaseWORKS and TREAT solutions.

Designed to scale across the VitalHub portfolio, AI Scribe brings practical AI capabilities directly into existing solutions. As a natively embedded module, the solution integrates seamlessly into the workflows organizations already rely on, enabling adoption without additional systems, interfaces, or disruption to daily operations.

AI Scribe is part of VitalHub’s growing investment in AI-powered capabilities. As both a developer and acquirer of best-of-breed software solutions, VitalHub is uniquely positioned to embed AI solutions across a broad range of workflows, delivering scalable technologies that help customers meet evolving demands while remaining focused on the people they serve.

Canadian Mental Health Association Waterloo Wellington (“CMHA WW”) became the first organization to deploy VitalHub AI Scribe through the CaseWORKS case management solution. Beginning with its intake teams, CMHA WW will benefit from AI-assisted documentation to improve efficiency, staff productivity, and client service delivery.

CaseWORKS and TREAT collectively support an initial serviceable market of approximately 22,000 practitioners. This expansion demonstrates the portability of VitalHub’s AI capabilities across its product portfolio and provides a repeatable model for delivering new functionality through the software environments customers and practitioners already use.

“AI Scribe reflects VitalHub’s approach to delivering practical AI that addresses real-world challenges for our customers,” said Dan Matlow, CEO of VitalHub. “We see significant opportunities to extend this capability across our portfolio and are pleased to begin with CMHA WW.”

“Our staff are passionate about supporting the individuals that we serve, and are often burdened by documentation requirements that continue to grow,” said Helen Fishburn, CEO of CMHA WW. “We sought a solution that could help reduce time spent on administrative tasks without disrupting how our staff work. The AI Scribe module is helping to streamline documentation, and giving our team members more time to focus on what matters most, supporting our clients and community.”

About VitalHub

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka. For more information about VitalHub (TSX:VHI) (OTCQX:VHIBF), please visit www.vitalhub.com and LinkedIn.

About Canadian Mental Health Association Waterloo Wellington

The Canadian Mental Health Association Waterloo Wellington is a non-profit organization that provides a full care system for those with addictions, mental health or developmental needs. We serve everyone from children to adults to seniors, all under one roof. Our programs help individuals and families to lead lives filled with meaning and promise. We have 450 staff at offices in Cambridge, Waterloo, Kitchener, Guelph, Fergus, and Mount Forest. We also provide visiting/satellite services in Arthur, Shelburne, Erin, and Palmerston. For more information, please visit www.cmhaww.ca.

Contact Information

Christian Sgro, CPA, CA, CFA
Head of IR and M&A Specialist
(365) 363-6433
christian.sgro@vitalhub.com

Dan Matlow
Chief Executive Officer, Director
(416) 727-9061
dan.matlow@vitalhub.com

Cautionary Statement

Certain statements contained in this news release may constitute “forward-looking information” or “financial outlook” within the meaning of applicable securities laws that involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking information or financial outlook. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “is expected”, “expects”, “scheduled”, “intends”, “contemplates”, “anticipates”, “believes”, “proposes” or variations (including negative variations) of such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such statements are based on the current expectations of the management of each entity and are based on assumptions and subject to risks and uncertainties. Although the management of each entity believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

Independent evaluation finds the regulated supply chain functioning positively and gaining preference with consumers

Company remains a committed community partner; sees opportunities for stronger consumer protections to create a model framework reflective of Dutch leadership and innovation

GRONINGEN, Netherlands, Sept. 15, 2026 (GLOBE NEWSWIRE) — Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today welcomed the publication of the first-year findings from the Netherlands’ regulated cannabis program, and reaffirmed its long-term commitment to the program and to the Dutch communities in which it operates. Village Farms Netherlands participates in the program as one of ten producers licensed by the Dutch government to cultivate and distribute cannabis to participating coffeeshops.

The evaluation, conducted by the Trimbos Institute, RAND Europe and Breuer & Intraval on behalf of the Dutch government, assessed the first year of the program’s operational phase across the ten participating municipalities. It reported that stakeholders across the supply chain, including coffeeshops, growers, municipalities and regulators, described their early experiences as positive, and that product range widened, with consumers rating price-value more positively than before the experiment began. It recorded no clear difference in public health, livability or safety compared to non-participating municipalities.

Michael DeGiglio, President and Chief Executive Officer of Village Farms, commented, “What the Dutch government set out to do was a historic undertaking for regulated cannabis in Europe and it deserves considerable praise. Replacing a tolerated supply chain with a regulated one is not an easy task, but these first-year findings are an encouraging sign of early success. We’re invested here as long-term community partners, and our team remains committed to collaborating with local stakeholders to build a successful program that protects consumers and creates economic benefits for its local communities.”

Orville Bovenschen, President of Global Operations for Village Farms, oversees operations for the Company’s two Dutch facilities.

Bovenschen commented, “What we bring to the Netherlands goes well beyond cannabis. We draw on decades of experience in controlled environment agriculture and regulated markets, with expertise in process innovation and product quality, compliance and responsible operations. We’ve applied those lessons while working closely with our local municipalities to meet the requirements of this new regulated market, and we’ll continue sharing our experience and insight with Dutch policymakers and regulators to build a model framework reflective of Dutch leadership and innovation.”

Bovenschen added, “We’re encouraged by these positive initial results, and we believe now is an appropriate time for the government to begin talking about ways to create stronger protections for consumers and longer-term certainty for the program. We are supportive of revisions to packaging and labeling requirements to avoid consumer preferences shifting to high potency products, and also see benefits to further expansion of the program to combat the illicit market. Getting these conversations started will give growers, coffeeshops, and municipalities the confidence to plan and invest for a much larger, successful regulated market.”

About Village Farms International

Village Farms is a global leader in cannabis, plant-based consumer packaged goods, and sustainable innovation. With a legacy built on decades of Controlled Environment Agriculture expertise and Dutch farming practices, today the Company is one of the world’s largest and most profitable cannabis operators with an asset portfolio that spans over 7 million square feet of advanced greenhouse and indoor cultivation assets.

In Canada, Village Farms operates the world’s largest EU-GMP certified cannabis facility at its production campus in Delta, British Columbia, and exports products to international medical markets. The Company is also a market share leader in dried flower formats and produces and distributes some of the country’s highest quality and best-selling strains, including its flagship Pure Sunfarms Pink Kush, one of the most widely consumed strains on the planet. Village Farms’ Canadian brand portfolio includes Pure Sunfarms, Fraser Valley Weed Co., Soar, Super Toast, Pure Laine, Tam Tams and Promenade.

In the Netherlands, the Company is one of only ten licensed operators in the country’s regulated cannabis program, and in the United States its CBDistillery brand is one of the country’s premier cannabinoid wellness platforms, and it also holds equity interests in cannabis businesses in Australia and Germany. Beyond cannabis, the Company holds an equity interest in Verdexa Holdings, a private venture pursuing strategic acquisitions to build a premier branded food platform, and its Clean Energy division transforms landfill gas into renewable natural gas and receives royalties on all revenues generated.

Contacts

Sam Gibbons, SVP, Corporate Affairs Email: sgibbons@villagefarms.com

Danielle Allore, Senior Manager, Communications Email: dallore@villagefarms.com

MISSISSAUGA, Ontario, Sept. 15, 2026 (GLOBE NEWSWIRE) — Next Hydrogen Solutions Inc. (“Next Hydrogen” or the “Company”) is pleased to announce that it has secured a non-repayable contribution agreement with the Government of Canada through Natural Resources Canada’s Energy Innovation Program (NRCan) for funding of up to $2 million for additional research to develop scalable fabrication processes for commercial electrolyzer modules.

This funding will support R&D activities focused on improving the efficiency, performance and cost of Next Hydrogen’s commercial electrolyzer modules. As an initial project milestone, the Company is targeting cell performance of 1.8 V/cell at 1.0 A/cm² by Q1 2027, consistent with the U.S. Department of Energy (DOE) 2026 technical target for alkaline water electrolysis. The project’s ultimate performance target is 1.7 V/cell at 1.2 A/cm², targeted for achievement by September 2028.

The technologies developed through this project are expected to enhance the competitiveness of Next Hydrogen’s commercial products by lowering energy consumption and reducing the cost of green hydrogen production. As electricity accounts for 60–70% of hydrogen production operating costs, these efficiency gains are expected to reduce electricity consumption of its electrolyzer modules per kilogram of hydrogen produced by approximately 8% as well as reducing the cost of fabricating its electrolyzers.

We anticipate achieving the initial 1.8 V/cell at 1.0 A/cm² performance milestone by Q1 2027, with the project continuing toward the ultimate target of 1.7 V/cell at 1.2 A/cm² by September 2028.

“We are grateful for NRCan’s support of this important initiative,” said Jocelyne Moyer, President and CEO of Next Hydrogen. “This investment will help advance our electrolyzer technology to have performance levels aligned with the U.S. DOE/H2NEW long-term vision for alkaline water electrolysis while supporting lower hydrogen production costs for our customers. We expect the innovations developed through this project to be incorporated into our commercial electrolyzer platform in early 2027, further enhancing its efficiency and competitiveness. By improving project economics and making clean hydrogen more affordable, this initiative can help accelerate market adoption while reinforcing Canada’s leadership in hydrogen innovation and the transition to a low-carbon economy.”

“Building Canada’s energy future depends on building and scaling the technologies that will power our economy for decades to come. Investments in Canadian innovators like Next Hydrogen are strengthening our energy security, supporting growth and turning Canadian expertise into real-world solutions. By supporting innovation today, we are building the stronger, more competitive energy sector Canada needs for generations to come.” said the Honourable Tim Hodgson, Minister of Energy and Natural Resources.

About Next Hydrogen

Founded in 2007, Next Hydrogen is a designer and manufacturer of electrolyzers that use water and electricity to generate clean hydrogen for use as a clean energy source. Next Hydrogen’s unique cell design architecture supported by over 40 patents enables superior dynamic response to efficiently convert intermittent renewable electricity into green hydrogen on a commercial infrastructure scale.

Contact Information

Jocelyne Moyer, President and CEO
Email: jmoyer@nexthydrogen.com
Phone: 416-317-0566

www.nexthydrogen.com

Cautionary Statements

This news release contains “forward-looking information” and “forward-looking statements”. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the risks associated with the hydrogen industry in general; delays or changes in plans with respect to infrastructure development or capital expenditures; cell efficiency targets; expected order sizes for the product line; customer relationships and customer terms for testing of products at a customer site; the ability of the Corporation to optimize energy efficiencies; the Corporation’s available resources to grow its sales backlog; uncertainty with respect to the timing of any contemplated transactions or partnerships, or whether such contemplated transactions or partnerships will be completed at all; whether the uncertainty of estimates and projections relating to costs and expenses; failure to obtain necessary regulatory approvals; health, safety and environmental risks; uncertainties resulting from potential delays or changes in plans with respect to infrastructure developments or capital expenditures; currency exchange rate fluctuations; as well as general economic conditions, stock market volatility and the ability to access sufficient capital. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, there will be no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.

Strategic Highlights: 

  1. Palomino Laboratories, Inc. Co-founder Steven P. DenBaars will present at MicroLED Connect 2026 on Thursday, September 17, 2026, at 11:50 a.m. (Central European Time) at the High Tech Campus in Eindhoven, the Netherlands.
  2. DenBaars’ presentation, “Development of GaN Based MicroLED Devices for Full Color Displays and High-Speed Optical Communication,” will highlight the role of improved microLED device design in enabling higher-speed data transmission and the potential for energy-efficient optical interconnects supporting AI infrastructure and data-center applications.

GOLETA, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) — Palomino Laboratories, Inc. (OTCQB: PALX) (‘Palomino’ or the ‘Company’), an artificial intelligence (AI) interconnect technology company, today announced that Co-founder and Director Steven P. DenBaars will present at MicroLED Connect 2026 on Thursday, September 17, 2026, at 11:50 a.m. CEST at the High Tech Campus in Eindhoven, the Netherlands.

Professor DenBaars’ presentation, “Development of GaN Based MicroLED Devices for Full Color Displays and High Speed Optical Communication,” will highlight advances in gallium nitride (GaN) microLED materials, device efficiency, and integration approaches supporting next-generation display and optical communication applications. The presentation will address how improved microLED device design can support higher-speed data transmission and the potential for energy-efficient optical interconnects for AI infrastructure and data-center environments.

Jeffrey B. Shealy, Co-Founder and CEO, commented: “AI infrastructure is being constrained by power and bandwidth limits in short-reach data movement, and the next wave of optical interconnect innovation will be defined by higher efficiency and higher speed in compact form factors.” Mr. Shealy continued, “Prof. DenBaars’ presentation at MicroLED Connect 2026 highlights advances in GaN-based microLED devices that can help enable faster data transmission and more energy-efficient optical interconnects for AI and data-center environments. As Palomino advances its roadmap, we believe microLED-enabled optical interconnects represent a compelling opportunity to improve performance-per-watt across next-generation AI systems.”

MicroLED Connect 2026 is hosted at the High Tech Campus in Eindhoven, the Netherlands. Additional conference information is available here.

About Palomino Laboratories

Palomino Laboratories is an artificial intelligence (AI) interconnect technology company headquartered in Goleta, California, developing next-generation connectivity solutions for the rapidly evolving AI infrastructure market. The Company’s product focus addresses AI interconnect solutions in the 0-to-50 meters range and includes: (i) silicon chipsets enhancing the speed of copper, (ii) silicon optical integrated circuits (IC’s) optimizing the performance of MicroVCSEL interconnects, and (iii) silicon and gallium nitride IC’s for MicroLED interconnects. Our chipsets enable high-bandwidth, low-latency, and energy-efficient data movement across AI systems. Palomino’s solutions are designed to support the growing performance demands of AI, high-performance computing (HPC), enterprise networking, hyperscale data centers and advanced robotics as increasingly intelligent systems require faster, more efficient, and more reliable data connectivity.

For more information, please visit www.palominolabs.ai.

Forward-Looking Statements
This release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and other statements that are predictive in nature, that depend upon or refer to future events or conditions. All statements other than statements of historical fact are statements that could be forward-looking statements. Forward-looking statements include words such as “expects,” “anticipates,” “intends,” “plans,” “could,” “believes,” “estimates” and similar expressions. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements Forward-looking statements are subject to a number of risks and uncertainties, including, but not limited to, the factors listed under “Risk Factors” in the Company’s filings with the SEC, including Forms 10-K, 10-Q and 8-K. Investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this release. Except as may be required by law, the Company does not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For further information
Palomino Laboratories Inc.
Jeffrey B. Shealy, CEO
Email: IR@palominolabs.ai

TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) — Lahontan Gold Corp. (TSXV:LG, OTCQB:LGCXF, FSE:Y2F) (the “Company” or “Lahontan”) is pleased to announce additional results from its 2026 Sonic core drilling program at the Santa Fe Mine Project. The ten drill holes reported below were all located on Santa Fe Mine Heap Leach Pad Two (“HLP Two”) and total 168.9 metres. Nearly every drill interval (0.76m) contains meaningful gold and silver mineralization, not unexpected given that the program is evaluating a historic heap leach pad (please see table and map below).

2026-09-14 at 6.54.17 PM

Notes: Au Eq equals Au (g/t) + ((Ag g/t/60)*0.70). Silver grade for calculating Au Eq is adjusted to consider historic metallurgical recovery as described in the Santa Fe Project Technical Report*. All drill holes are vertical, true thickness of the intercepts are approximately 100% of the drilled interval. Numbers may not total precisely due to rounding.

HLP Two was utilized by Corona Gold to process run-of mine (“ROM” or uncrushed) gold and silver mineralized rock from the Santa Fe open pit during the late 1980’s and early 1990’s. Detailed production records show that 3.76M tonnes of rock grading 0.55 g/t Au, 2.9 g/t Ag (0.58 g/t Au Eq) was loaded on HLP Two and, based on reported recoveries (47% Au, 13% Ag), the expected residual grade would average about 0.29 g/t Au and 2.5 g/t Ag (0.32 g/t Au Eq). Based on these first ten drill holes (out of 26 completed), the weighted average grade of all samples to date is 0.50 g/t Au, 3.3 g/t Ag (0.54 g/t Au Eq). CN Au analyses vary from to 5 to 82% of the coresponing fire assay Au value and average 40%, suggesting that the heap leach pad material may be amenable to reprocessing using conventional CN leaching. Unique to drilling heap leach pads, mine dumps, or tailings, is a lack of systematic geologic or other technical controls to grade distribution, so grade variability is expected.

Kimberly Ann, Founder, Chair, CEO, and President of Lahontan Gold Corp commented: “The results from the Sonic core drilling of HLP Two are very encouraging. The drill holes confirm the presence of significant residual gold and silver mineralization in HLP Two. Additional drill results will be needed before Mineral Resources can be calculated; however, the program is clearly off to an excellent start. There are 86 additional Sonic drill holes spread across the four historic heap leach pads, so expect additional results as assays are provided by the lab.”

Screenshot 2026-09-14 at 6.55.43 PM

Drill hole location, Heap Leach Pad Two, Santa Fe Mine Project, Mineral County, Nevada. Drill holes shown are the SF26-XXXS series of Sonic core drill holes.

QA/QC Protocols

Lahontan conducts an industry standard QA/QC program for its core, Sonic, and RC drilling programs. The QA/QC program consisted of the insertion of coarse blanks and Certified Reference Materials (CRM) into the sample stream at random intervals. The targeted rate of insertion was one QA/QC sample for every 16 to 20 samples. Coarse blanks were inserted at a rate of one coarse blank for every 65 samples or approximately 1.5% of the total samples. CRMs were inserted at a rate of one CRM for every 20 samples or approximately 5% of the total samples.

The standards utilized include three gold CRMs and one blank CRM that were purchased from MEG, LLC of Lamoille, Nevada (formerly Shea Clark Smith Laboratories of Reno, Nevada). Expected gold values are 0.188 g/t, 1.107 g/t, 10.188 g/t, and -0.005 g/t, respectively. CRMs with similar grades are inserted as the initial CRM’s run out. The coarse blank material comprised of commercially available landscape gravel and unaltered Tertiary volcanic rock have an expected gold value of -0.005 g/t.

As part of the RC drilling QA/QC process, duplicate samples were collected of every 20th sample interval at the drill rig to evaluate sampling methodology. Samples were collected from the reject splitter on the drill rig cyclone splitter. Samples were collected at each 95- to 100-foot (28.96 – 30.48m) mark and labeled with a “D” suffix on the sample bag. No duplicates were submitted for Sonic core drill holes.

All drill samples were sent to American Assay Laboratories (AAL) in Sparks, Nevada, USA for analyses. Delivery to the lab was either by a Lahontan Gold employee or by an AAL driver. Analyses for all RC and core samples consisted of Au analysis using 30-gram fire assay with ICP finish, along with a 36-element geochemistry analysis performed on each sample utilizing two acid digestion ICP-AES method. Tellurium or 50-element analyses were performed on select drill holes utilizing ICP-MS method. Cyanide leach analyses, using a tumble time of 2 hours and analyzed with ICP-AES method, were performed on select drill holes for Au and Ag recovery. AAL inserts their own blanks, standards and conducts duplicate analyses to ensure proper sample preparation and equipment calibration. We have all results reported in grams per tonne (g/t).

About Lahontan Gold Corp.

Lahontan Gold Corp. is a Nevada-focused mine development company advancing a portfolio of four gold and silver projects in mining-friendly Nevada’s prolific Walker Lane. The Company’s primary focus is the restart of its flagship, the 28.3 km² Santa Fe Mine project, with a targeted return to production in 2027.

  • Santa Fe Mine historic production: 359,202 ounces of gold and 702,067 ounces of silver, open pit mining with heap-leach processing (1988-1995; Nevada Bureau of Mines).
  • Current Resources: The Santa Fe Mine has a NI 43-101 compliant Indicated Mineral Resource of 1,195,000 oz Au Eq (47,532,000 tonnes grading 0.72 g/t Au and 5.55 g/t Ag, together grading 0.78 g/t Au Eq) and an Inferred Mineral Resource of 1,190,000 oz Au Eq (60,605,000 tonnes grading 0.59 g/t Au and 2.40 g/t Ag, together grading 0.61 g/t Au Eq), all pit constrained (Au Eq is inclusive of recovery, please see Santa Fe Project Technical Report and note below*).
  • Objectives 2026:
    • Complete an updated Preliminary Economic Assessment (“PEA”) for the Santa Fe Mine, including the first analysis of mining and processing sulfide resources,
    • Advancing mine permitting activities with the objective of commencing construction in 2027,
    • Continue drill testing the satellite West Santa Fe project, with a maiden resource estimate targeted by year-end,
    • Conduct exploration drilling at Santa Fe focused on expanding known gold and silver mineralization,
    • Drill test historic heap-leach pads to evaluate residual gold and silver mineralization for potential future reprocessing opportunities.

For more information, please visit our website: www.lahontangoldcorp.com

* Please see the “Updated Mineral Resource Estimate, NI 43-101 Technical Report, Santa Fe Project”, Authors: Michael S. Lindholm, C.P.G., and Thomas Dyer, PE; Effective Date: August 13, 2026, Report Date: Maximum 45 days from August 17, 2026. The Technical Report will be available on the Company’s website and SEDAR+. Mineral resources are reported using a cut-off grade of 0.10 g/t AuEq for oxide and transition resources and 0.30 g/t AuEq for non-oxide resources. AuEq for the purpose of cut-off grade and reporting the Mineral Resources is based on the following assumptions gold price of US$3,250/oz gold, silver price of US$40.00/oz silver, and oxide gold recoveries ranging from 60% to 79%, oxide silver recoveries ranging from 0% to 30%, transitional gold recoveries ranging from 28% to 45%, transitional silver recoveries ranging from 0 to 13%, and non-oxide gold and silver recoveries of 68% except for the York deposit where non-oxide recoveries are estimated to be 0%.

Qualified Person

Brian J. Maher, M.Sc., CPG-12342, is a “Qualified Person” as defined under Canadian National Instrument 43-101, Standards of Disclosure for Mineral Projects, and has reviewed and approved the content of this news release in respect of all technical disclosure other than the Mineral Resource Estimate as noted above.‎ Mr. Maher is Senior Vice President, Mine Development & Exploration for Lahontan Gold and has verified the data disclosed in this news release, including the sampling, ‎‎analytical and test data underlying the disclosure.

On behalf of the Board of Directors

Kimberly Ann

Founder, CEO, President, Executive Chair

FOR FURTHER INFORMATION, PLEASE CONTACT:

Lahontan Gold Corp.

Kimberly Ann

Founder, CEO, President, Executive Chair

Phone: 1-530-414-4400

Email:
Kimberly.ann@lahontangoldcorp.com

Website: www.lahontangoldcorp.com

Cautionary Note Regarding Forward-Looking Statements:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Except for statements of historical fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the TSXV. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com.

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/20a2bb0c-6da0-4051-9a55-564b48955150
https://www.globenewswire.com/NewsRoom/AttachmentNg/22f0b7db-2c91-4ce4-ae55-d325c84d506f

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.